|
|
Volumn 19, Issue 3, 2011, Pages 427-428
|
|
Hemophilia gene therapy: A holy grail found
a
a
Editorial Board
*
(United States)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BLOOD CLOTTING FACTOR 8;
BLOOD CLOTTING FACTOR 9;
CAPSID PROTEIN;
NEUTRALIZING ANTIBODY;
PARVOVIRUS VECTOR;
VIRUS VECTOR;
ADENO ASSOCIATED VIRUS;
ANTIBODY TITER;
COST CONTROL;
DRUG COST;
EDITORIAL;
GENE EXPRESSION;
GENE THERAPY;
GENETIC TRANSDUCTION;
HEMOPHILIA A;
HEMOPHILIA B;
HUMAN;
IN VITRO STUDY;
NONHUMAN;
PATIENT SAFETY;
TREATMENT OUTCOME;
VIRAL GENE DELIVERY SYSTEM;
VIRUS PARTICLE;
GENE THERAPY;
HEMOPHILIA A;
HUMANS;
|
|
EID: 79952149008
PISSN: 15250016
EISSN: 15250024
Source Type: Journal
DOI: 10.1038/mt.2011.13 Document Type: Editorial |
|
Times cited : (32)
|
|
References (0)
|
